Immune thrombocytopenia (ITP), formerly known as idiopathic thrombocytopenic purpura, is an autoimmune bleeding disorder that causes a low platelet count. Because platelets help the blood clot, people with ITP may bruise or bleed more easily than usual.
For some, ITP causes few or no noticeable symptoms. For others, frequent bruising, nosebleeds, petechiae, or other bleeding can be the first sign that something isn’t right.
Understanding the signs and symptoms of ITP, how it is diagnosed and the treatment options available can make navigating the condition a little clearer.
ITP is an autoimmune disorder in which the immune system mistakenly targets and destroys platelets. The body may also have difficulty producing enough new platelets to replace them.
A normal platelet count generally ranges from about 150,000 to 450,000 platelets per microliter of blood. People with ITP have platelet counts below the normal range, although the number and severity of symptoms can vary significantly from person to person.
ITP can affect both children and adults. In children, it may develop suddenly, sometimes following a viral infection, and often resolves over time. Adults are more likely to experience persistent or chronic ITP that requires ongoing monitoring or treatment.
The exact cause of ITP is not always known. In fact, the word idiopathic means that a condition develops without a clearly identifiable cause, which is why ITP was historically called idiopathic thrombocytopenic purpura.
Today, we know that ITP is an immune-mediated condition. The immune system mistakenly identifies platelets as something it should attack, leading to their premature destruction.
ITP may occur on its own or alongside another condition. In some people, infections, certain medications, or other immune system changes may be associated with its development.
ITP symptoms are primarily related to a low platelet count and an increased tendency to bruise or bleed. Some people have no symptoms and only discover they have ITP after a routine blood test.
Common signs and symptoms of ITP can include:
Symptoms can range from mild to severe and may change as platelet counts rise and fall.
Severe bleeding is uncommon, but very low platelet counts can increase the risk of serious internal bleeding. Bleeding that is severe or will not stop requires immediate medical attention.
There is no single test that confirms ITP. Instead, healthcare providers typically diagnose it by evaluating platelet levels and ruling out other possible causes of thrombocytopenia, or low platelets.
Diagnosis may include:
In some circumstances, additional testing may be recommended based on a patient’s age, symptoms, or medical history.
Because several conditions can cause low platelet counts or similar symptoms, an accurate diagnosis is an important first step toward finding the right treatment plan.
When treatment is needed, the right approach depends on the individual, including platelet count, bleeding symptoms, previous treatments, overall health, and personal preferences. Treatment options may include:
Corticosteroids
Steroids are commonly used as an initial treatment to reduce immune system activity and help increase platelet counts.
Intravenous Immunoglobulin (IVIG)
IVIG can help raise platelet levels relatively quickly. It may be used when a faster response is needed, including in certain cases of significant bleeding or before a procedure.
Thrombopoietin Receptor Agonists (TPO-RAs)
Medications such as romiplostim, eltrombopag, and avatrombopag stimulate the bone marrow to produce more platelets and may be considered for adults with persistent or chronic ITP.
Other Targeted and Immune-modulating Therapies
For people who need additional treatment, options may include rituximab, fostamatinib, rilzabrutinib, or other therapies that target different parts of the immune system or platelet-production process. The best choice depends on the individual and their response to previous treatments.
Splenectomy
Surgical removal of the spleen may also be considered for some people with persistent or chronic ITP, particularly when other treatments have not provided an adequate response.
ITP treatment is highly individualized, and not every therapy is appropriate for every patient. The goal is generally to maintain a platelet level that helps prevent significant bleeding while minimizing treatment-related risks and supporting quality of life. Patients and their healthcare providers can work together to determine the approach that best fits their individual needs.
The outlook for people with ITP varies.
Many children with acute ITP recover within several months, sometimes without treatment. Adults are more likely to develop persistent or chronic ITP, but the condition can often be managed with appropriate monitoring and treatment.
Some people experience remission, while others have platelet counts that fluctuate over time or require ongoing therapy.
Working closely with a hematology care team can help patients understand their platelet levels, recognize changes in symptoms, and determine when treatment may be needed.
There is no single guaranteed cure for ITP. Some people experience long-term remission, meaning their platelet counts improve, and they no longer require treatment. Others may have chronic ITP that requires ongoing monitoring or therapy.
For most people, ITP can be successfully managed. Serious internal bleeding is rare but can occur, particularly when platelet counts are extremely low. Your healthcare provider can help you understand your individual bleeding risk.
Early ITP symptoms may include unexplained bruising, petechiae, frequent nosebleeds, bleeding gums, or heavier-than-usual menstrual bleeding. Some people have no noticeable symptoms and are diagnosed after a blood test shows a low platelet count.
There is not always an identifiable trigger. ITP is caused by an abnormal immune response against platelets and may sometimes develop following an infection or in association with another immune condition.
Many children with ITP recover within several months, often without treatment. Others may develop persistent or chronic ITP, making continued follow-up with their healthcare team important.
Depending on platelet levels and bleeding risk, a healthcare provider may recommend avoiding certain medications, supplements, or activities that could increase the chance of bleeding. Aspirin and NSAIDs such as ibuprofen can affect platelet function and should be discussed with your healthcare provider before use.
An ITP diagnosis can bring uncertainty, but understanding your condition and having the right support can make the path forward feel more manageable.
Keep an open line of communication with your healthcare team, know which symptoms require attention, and follow recommendations for platelet monitoring and treatment. Organizations such as the Platelet Disorder Support Association (PDSA) can also connect patients and families with education, support groups, and other resources.
When IVIG is part of an ITP treatment plan, LUX Infusion helps make the experience simpler from the start.
Our experienced clinical and care coordination teams work closely with patients, caregivers, and prescribing providers to support each step of therapy, from insurance navigation and medication coordination to personalized education and ongoing clinical support.
Depending on location, eligible patients may receive infusion therapy in the comfort of home or at a LUX Infusion location.
Because complex care should feel a little less complicated.
Learn more about immunoglobulin therapy and how LUX Infusion supports patients throughout treatment.
If you or a patient you care for needs infusion therapy and is looking for a care partner who can help navigate coverage, coordination, and site-of-care options, we are here. Referring providers can submit a referral on our website. A welcome call goes out within four hours. If you’re a patient, click here.
Your care is complex. Getting started shouldn’t be.
LUX Infusion is elevating infusions into an experience. As a U.S.-based, clinician-led infusion services company, we provide both home infusion and ambulatory infusion center services, bringing clarity, compassion, and expertise to every patient relationship. With faster therapy starts, dedicated patient support, and continuous data sharing with providers, LUX Infusion ensures patients feel supported, and providers and partners can trust in better adherence and outcomes. For more information, visit luxinfusion.com.
Disclaimer: This content is for informational purposes only and is not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider, or as legal advice. Please consult a physician or other healthcare professional for your specific health care and/or medical needs or concerns and never disregard professional medical advice or delay in seeking it because of something you have read here or on our website.
References
